Novartis Message Board - Msg: 2177216

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novartis

NVS 126.59

+0.9%

Nov 6 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Garrison who wrote (54)	9/12/1997 7:17:00 AM
From: Jim Garrison	of 296

Osteoporosis conference "very excited" about drug marketed by Novartis : (I like the MRK version better): Studies may offer hope for osteoporosis victims biz.yahoo.com Excerpts: "The National Osteoporosis Foundation said it was especially excited about work with calcitonin-salmon, a synthetic version of a natural hormone that is now available as a nasal spray. It is sold in the United States by Novartis (NOVZN.S) and elsewhere by Cortecs International (CRI.AX). " .......... "The Foundation estimates that 10 million Americans have osteoporosis and 18 million more, mostly women, have low bone mass that puts them at risk. Experts say 200 million people worldwide suffer from the disease." This is the nvtsy version (not nearly as informative): Studies may offer hope for osteoporosis victims biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next